Elite Pharmaceuticals ELTP
OTC ELTP
$0.24 +0.00 (+0.00%)
As of: Oct 21, 2026 · 11:00 AM EDT

Elite Pharmaceuticals (ELTP) Total Liabilities (2011 - 2026)

Updated

Elite Pharmaceuticals (ELTP) recorded Total Liabilities of $34.84 million in fiscal Q1 2027 (quarter ended Jun 30, 2026), down 45.3% from $63.66 million a year earlier and down 11.6% from the prior quarter.

Analysis

Elite Pharmaceuticals (ELTP) Total Liabilities (2011 - 2026) Analysis & Trends

At the end of FY2026 (ended Mar 31, 2026), Elite Pharmaceuticals reported Total Liabilities of $39.41 million, down 8.1% from FY2025.

  • Annual Total Liabilities has a five-year compound annual growth rate of 31.5% (FY2021 to FY2026).
  • Across earlier fiscal years, Total Liabilities came in at $42.87 million in FY2025 (+64.4%), $26.07 million in FY2024 (+118.4%), $11.94 million in FY2023 (+20.2%) and $9.93 million in FY2022 (-1.1%).
  • The fiscal Q1 2027 figure is the lowest quarterly Total Liabilities since fiscal Q1 2025.
  • On a year-over-year basis, Total Liabilities has declined for three consecutive quarters, with growth averaging 37.4% over the last eight quarters.
  • Peak year-over-year performance for Total Liabilities in the last five years was growth of 146.2% in fiscal Q3 2023, against a decline of 45.3% in fiscal Q1 2027 at the low end.
  • Per Business Quant, the preceding three fiscal quarters came in at $39.41 million (Q4 2026), $46.1 million (Q3 2026) and $55.66 million (Q2 2026).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Liabilities (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn 108.40 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn 116.09 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn 141.05 Bn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn 87.82 Bn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn 80.09 Bn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn 65.46 Bn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn 83.95 Bn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn 37.53 Bn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn 115.64 Bn
10 Elite Pharmaceuticals 268.12 Mn 149.80 Mn 13.51 Mn 34.84 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 34.84 Mn
Mar 31, 2026 39.41 Mn
Dec 31, 2025 46.10 Mn
Sep 30, 2025 55.66 Mn
Jun 30, 2025 63.66 Mn
Mar 31, 2025 42.87 Mn
Dec 31, 2024 54.31 Mn
Sep 30, 2024 40.93 Mn
Jun 30, 2024 29.60 Mn
Mar 31, 2024 26.07 Mn
Dec 31, 2023 28.28 Mn
Sep 30, 2023 25.62 Mn
Jun 30, 2023 16.38 Mn
Mar 31, 2023 11.94 Mn
Dec 31, 2022 22.54 Mn
Sep 30, 2022 23.15 Mn
Mar 31, 2022 9.93 Mn
Dec 31, 2021 9.16 Mn
Sep 30, 2021 10.12 Mn
Jun 30, 2021 11.29 Mn
API Access

Elite Pharmaceuticals Total Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-liabilities&ticker=ELTP&period=max&api_key=YOUR_API_KEY